NF2 and lung carcinoma: In summary, we demonstrated that hypoxic BMSC‐derived EVs could deliver miR‐328‐3p to target the NF2 gene, which inhibited the Hippo pathway, thereby promoting the occurrence and progression of lung cancer (Figure 8).